• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录组分析揭示了转移性葡萄膜黑色素瘤免疫微环境的新见解及新型生物标志物的上调。

Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma.

作者信息

Krishna Yamini, Acha-Sagredo Amelia, Sabat-Pośpiech Dorota, Kipling Natalie, Clarke Kim, Figueiredo Carlos R, Kalirai Helen, Coupland Sarah E

机构信息

Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Duncan Building, Daulby Street, Liverpool L69 3GA, UK.

Liverpool Ocular Oncology Research Centre, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, William Henry Duncan Building, West Derby Street, Liverpool L7 8TX, UK.

出版信息

Cancers (Basel). 2020 Sep 30;12(10):2832. doi: 10.3390/cancers12102832.

DOI:10.3390/cancers12102832
PMID:33008022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7650807/
Abstract

Metastatic uveal melanoma (mUM) to the liver is incurable. Transcriptome profiling of 40 formalin-fixed paraffin-embedded mUM liver resections and 6 control liver specimens was undertaken. mUMs were assessed for morphology, nuclear BAP1 (nBAP1) expression, and their tumour microenvironments (TME) using an "immunoscore" (absent/altered/high) for tumour-infiltrating lymphocytes (TILs) and macrophages (TAMs). Transcriptomes were compared between mUM and control liver; intersegmental and intratumoural analyses were also undertaken. Most mUM were epithelioid cell-type (75%), amelanotic (55%), and nBAP1-ve (70%). They had intermediate (68%) or absent (15%) immunoscores for TILs and intermediate (53%) or high (45%) immunoscores for TAMs. M2-TAMs were dominant in the mUM-TME, with upregulated expression of , , , , , , and . Compared to control liver, mUM showed significant ( < 0.01) upregulation of 10 genes: , , , , , , , , , and . Protein expression of DUSP4, CD44, IRF4, BCL-2, CD146, and IGF1R was validated in all mUMs, whereas protein expression of PRAME was validated in 10% cases; LGALS3 stained TAMs, and MFGEF8 highlighted bile ducts only. Intersegmental mUMs show differing transcriptomes, whereas those within a single mUM were similar. Our results show that M2-TAMs dominate mUM-TME with upregulation of genes contributing to immunosuppression. mUM significantly overexpress genes with targetable signalling pathways, and yet these may differ between intersegmental lesions.

摘要

转移性葡萄膜黑色素瘤(mUM)至肝脏是无法治愈的。对40例福尔马林固定石蜡包埋的mUM肝切除术标本和6例对照肝脏标本进行了转录组分析。使用针对肿瘤浸润淋巴细胞(TILs)和巨噬细胞(TAMs)的“免疫评分”(缺失/改变/高)对mUM进行形态学、核BAP1(nBAP1)表达及其肿瘤微环境(TME)评估。比较了mUM与对照肝脏之间的转录组;还进行了节段间和肿瘤内分析。大多数mUM为上皮样细胞类型(75%)、无色素性(55%)和nBAP1阴性(70%)。它们的TIL免疫评分为中等(68%)或缺失(15%),TAM免疫评分为中等(53%)或高(45%)。M2-TAMs在mUM-TME中占主导, 、 、 、 、 、 和 的表达上调。与对照肝脏相比,mUM显示10个基因显著(<0.01)上调: 、 、 、 、 、 、 、 、 和 。DUSP4、CD44、IRF4、BCL-2、CD146和IGF1R的蛋白表达在所有mUM中均得到验证,而PRAME的蛋白表达在10%的病例中得到验证;LGALS3染色TAMs,而MFGEF8仅突出胆管。节段间的mUM显示出不同的转录组,而单个mUM内的转录组相似。我们的结果表明,M2-TAMs在mUM-TME中占主导,导致免疫抑制的基因上调。mUM显著过表达具有可靶向信号通路的基因,但这些基因在节段间病变中可能有所不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/9749a76ef8ba/cancers-12-02832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/4135a498a6bd/cancers-12-02832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/52851e342c2b/cancers-12-02832-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/27f19837be15/cancers-12-02832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/5cad1b4ebf38/cancers-12-02832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/dd3a00912213/cancers-12-02832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/9749a76ef8ba/cancers-12-02832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/4135a498a6bd/cancers-12-02832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/52851e342c2b/cancers-12-02832-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/27f19837be15/cancers-12-02832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/5cad1b4ebf38/cancers-12-02832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/dd3a00912213/cancers-12-02832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e563/7650807/9749a76ef8ba/cancers-12-02832-g006.jpg

相似文献

1
Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma.转录组分析揭示了转移性葡萄膜黑色素瘤免疫微环境的新见解及新型生物标志物的上调。
Cancers (Basel). 2020 Sep 30;12(10):2832. doi: 10.3390/cancers12102832.
2
Inflammatory cell infiltrates in advanced metastatic uveal melanoma.晚期转移性葡萄膜黑色素瘤中的炎性细胞浸润。
Hum Pathol. 2017 Aug;66:159-166. doi: 10.1016/j.humpath.2017.06.005. Epub 2017 Jun 24.
3
Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.原发性中枢神经系统弥漫性大 B 细胞淋巴瘤的肿瘤微环境和免疫检查点特征。
Virchows Arch. 2020 Jun;476(6):891-902. doi: 10.1007/s00428-019-02695-6. Epub 2019 Dec 6.
4
Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.BAP1蛋白表达模式为葡萄膜黑色素瘤的预后意义及生物学特性提供了见解。
J Pathol Clin Res. 2017 Nov 13;4(1):26-38. doi: 10.1002/cjp2.86. eCollection 2018 Jan.
5
Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.葡萄膜黑色素瘤核 BRCA1 相关蛋白-1 免疫反应性是转移的指标。
Ophthalmology. 2018 Feb;125(2):203-209. doi: 10.1016/j.ophtha.2017.07.018. Epub 2017 Aug 18.
6
MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.MUC18/MCAM(CD146),一种人类T淋巴细胞的活化抗原。
J Immunol. 1997 Mar 1;158(5):2107-15.
7
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.PRAME作为转移性葡萄膜黑色素瘤免疫治疗的潜在靶点
JAMA Ophthalmol. 2017 Jun 1;135(6):541-549. doi: 10.1001/jamaophthalmol.2017.0729.
8
BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.免疫组织化学检测 BAP1 蛋白缺失:用于预测葡萄膜黑色素瘤患者预后的一种潜在有用的工具。
Pathology. 2013 Dec;45(7):651-6. doi: 10.1097/PAT.0000000000000002.
9
Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment.Hippo-YAP信号通路对肿瘤相关巨噬细胞(TAM)的影响及其对癌症免疫抑制微环境的意义。
Ann Transl Med. 2020 Mar;8(6):399. doi: 10.21037/atm.2020.02.11.
10
Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.巢蛋白在原发性和转移性葡萄膜黑色素瘤中的表达-可能是高危葡萄膜黑色素瘤的生物标志物。
Acta Ophthalmol. 2018 Aug;96(5):503-509. doi: 10.1111/aos.13645. Epub 2018 Jan 16.

引用本文的文献

1
Repurposed clindamycin suppresses pyroptosis in tumor-associated macrophages through Inhibition of caspase-1.重新利用的克林霉素通过抑制半胱天冬酶-1来抑制肿瘤相关巨噬细胞中的细胞焦亡。
J Exp Clin Cancer Res. 2025 Aug 4;44(1):225. doi: 10.1186/s13046-025-03478-5.
2
Bibliometric analysis of immunotherapy in treatment of uveal melanoma.葡萄膜黑色素瘤免疫治疗的文献计量分析
Medicine (Baltimore). 2025 Jun 20;104(25):e42932. doi: 10.1097/MD.0000000000042932.
3
An overview of BAP1 biological functions and current therapeutics.BAP1生物学功能及当前治疗方法概述。

本文引用的文献

1
Inhibition of ATM Increases the Radiosensitivity of Uveal Melanoma Cells to Photons and Protons.抑制 ATM 可增加葡萄膜黑色素瘤细胞对光子和质子的放射敏感性。
Cancers (Basel). 2020 May 28;12(6):1388. doi: 10.3390/cancers12061388.
2
Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma.对117份常规临床样本进行靶向二代测序,进一步深入了解葡萄膜黑色素瘤的分子格局。
Cancers (Basel). 2020 Apr 23;12(4):1039. doi: 10.3390/cancers12041039.
3
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells.
Biochim Biophys Acta Rev Cancer. 2025 Apr;1880(2):189267. doi: 10.1016/j.bbcan.2025.189267. Epub 2025 Jan 21.
4
Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation.揭示去细胞化后高转移风险葡萄膜黑色素瘤的结构微环境。
Sci Rep. 2024 Nov 5;14(1):26811. doi: 10.1038/s41598-024-78171-2.
5
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.黑色素瘤中 MIF、DDT 和 CD74 的预后和治疗见解。
Oncotarget. 2024 Jul 19;15:507-520. doi: 10.18632/oncotarget.28615.
6
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.黑色素瘤的异质性和分子特征:对靶向治疗的影响。
Mol Biomed. 2024 May 10;5(1):17. doi: 10.1186/s43556-024-00182-2.
7
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.麦角酰二乙胺对转移性葡萄膜黑色素瘤细胞具有抗癌作用,并调节其细胞和细胞外囊泡蛋白质组。
Open Res Eur. 2023 Nov 13;3:88. doi: 10.12688/openreseurope.15973.2. eCollection 2023.
8
BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.BAP1 突变抑制 NF-κB 信号通路,在葡萄膜黑色素瘤中诱导免疫抑制微环境。
Mol Med. 2023 Sep 14;29(1):126. doi: 10.1186/s10020-023-00713-7.
9
Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis.外周血基因在 COVID-19 和脓毒症之间的相互作用。
Int J Mol Sci. 2023 Jan 30;24(3):2591. doi: 10.3390/ijms24032591.
10
1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model.1,4-二羟基奎尼尼布在转移性异种移植模型中调节葡萄膜黑色素瘤肿瘤外植体的分泌组及氧化磷酸化标志物。
Front Med (Lausanne). 2023 Jan 9;9:1036322. doi: 10.3389/fmed.2022.1036322. eCollection 2022.
内质网应激介导葡萄膜黑色素瘤细胞对BCL-2抑制剂的耐药性。
Cell Death Discov. 2020 Apr 17;6:22. doi: 10.1038/s41420-020-0259-2. eCollection 2020.
4
Single-cell analysis reveals new evolutionary complexity in uveal melanoma.单细胞分析揭示葡萄膜黑色素瘤的新进化复杂性。
Nat Commun. 2020 Jan 24;11(1):496. doi: 10.1038/s41467-019-14256-1.
5
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.BAP1 表达缺失与葡萄膜黑色素瘤的免疫抑制微环境相关,这对免疫疗法的发展有影响。
J Pathol. 2020 Apr;250(4):420-439. doi: 10.1002/path.5384.
6
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma.药物组合的临床前评估确定 Bcl-2/XL/W 和 MDM2 的共同抑制作用是葡萄膜黑色素瘤的一种潜在治疗方法。
Eur J Cancer. 2020 Feb;126:93-103. doi: 10.1016/j.ejca.2019.12.012. Epub 2020 Jan 9.
7
Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region.3号染色体在BAP1基因区域的部分缺失在葡萄膜黑色素瘤中的重要性。
JAMA Ophthalmol. 2020 Feb 1;138(2):188-189. doi: 10.1001/jamaophthalmol.2019.5491.
8
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.双特异性蛋白磷酸酶 DUSP4 调节 BRAF 野生型黑色素瘤对 MEK 抑制的反应。
Br J Cancer. 2020 Feb;122(4):506-516. doi: 10.1038/s41416-019-0673-5. Epub 2019 Dec 16.
9
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.免疫系统逃逸作为黑色素瘤进展的标志:树突状细胞的作用。
Front Oncol. 2019 Nov 5;9:1148. doi: 10.3389/fonc.2019.01148. eCollection 2019.
10
Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.普瑞巴林通过抑制胰岛素样生长因子-1 受体及其下游通路来抑制葡萄膜黑色素瘤细胞的增殖。
J Cell Mol Med. 2019 Nov;23(11):7545-7553. doi: 10.1111/jcmm.14623. Epub 2019 Sep 11.